Understanding the New 2026 AHA/ACC Cholesterol Guidelines

A simple guide to what changed, why it matters, and how to protect your heart

Heart disease is still the number‑one cause of death in the United States. The American Heart Association (AHA) and American College of Cardiology (ACC) released new cholesterol (dyslipidemia) guidelines in 2026 to help people lower their risk earlier and more effectively.

These new guidelines replace the 2018 cholesterol guidelines and include major updates based on the latest science.

What’s New in the 2026 Guidelines?

Here are the biggest changes:

1. Cholesterol goals are back — and they’re lower than before

The new guidelines bring back specific LDL (“bad cholesterol”) targets. Lower numbers mean lower risk.

• People with very high‑risk heart disease: LDL < 55 mg/dL

• People with heart disease but not very high‑risk: LDL < 70 mg/dL

• People with LDL ≥190 mg/dL: goal < 100 mg/dL, or < 70 mg/dL if they also have family history or other risks

• People with LDL 70–189 mg/dL:

  • Low/borderline/intermediate risk → < 100 mg/dL

  • High risk → < 70 mg/dL

• People with coronary calcium (CAC) on CT scans:

  • CAC 1–99 → < 100 mg/dL

  • CAC ≥100 → < 70 mg/dL

  • CAC ≥1000 → < 55 mg/dL  

2. Earlier screening and treatment

The guideline encourages universal lipid testing across the lifespan and earlier treatment when needed — even in young adults with strong family history or high LDL.

3. Better tools to measure heart risk

Doctors now use the PREVENT‑ASCVD risk calculator instead of the older Pooled Cohort Equations. This tool estimates both 10‑year and 30‑year risk, helping people understand their lifetime heart risk.

4. New focus on important blood markers

The guidelines recommend:

• Testing lipoprotein(a) (Lp(a)) at least once in a lifetime

• Checking ApoB in certain cases to better understand risk

These markers help identify people who may need more aggressive treatment.

5. Coronary artery calcium (CAC) scans used more often

If it’s unclear whether someone needs medication, a CAC scan can help. A higher score means higher risk and a stronger need for treatment.

Why Did These Changes Happen?

The new guidelines reflect years of research showing

1. Lower LDL for longer = fewer heart attacks and strokes

Studies show that keeping LDL low over many years greatly reduces risk.

2. Heart disease starts earlier than we think

Plaque can build up silently for decades. Early testing and treatment help prevent problems later.

3. Some people have hidden risks

Markers like Lp(a) and ApoB can reveal risk even when regular cholesterol numbers look “okay.”

4. Personalized care works better

Using tools like PREVENT‑ASCVD and CAC scoring helps tailor treatment to each person’s real risk.

How Can You Use This Information to Protect Your Heart?

1. Get your cholesterol checked regularly

Ask your doctor how often you need testing based on your age, family history, and risk factors.

2. Know your LDL goal

Your goal depends on your risk level. Bring this up during your next visit.

3. Ask about Lp(a) testing

It’s a one‑time test that can reveal important genetic risk.

4. Talk about the PREVENT‑ASCVD score

This helps you understand your long‑term heart health.

5. Consider a CAC scan if your risk is unclear

This quick, low‑radiation CT scan can guide treatment decisions.

6. Focus on lifestyle — it still matters most

Even with new medications available, the foundation of heart health is still:

• Eating whole foods, less process food (culturally speaking: not none!)

• Moving your body

• Avoiding tobacco

• Getting enough sleep

• Managing stress

7. Don’t wait to start treatment if you need it

The new guidelines encourage starting medication earlier when lifestyle changes alone aren’t enough.

Final Thoughts on the 2026 new cholesterol guidelines

The 2026 AHA/ACC cholesterol guidelines are designed to help people prevent heart disease earlier, treat risk more effectively, and live longer, healthier lives.

Understanding your numbers — and your personal risk — is one of the most powerful steps you can take for your heart.

Resources:

AHA Cholesterol Education Resources (Patient‑Friendly)

1. Cholesterol Tools & Resources (AHA)

Printable sheets, Spanish versions, LDL guides, ASCVD explanations, and medication checklists. https://www.heart.org/en/health-topics/cholesterol/cholesterol-tools-and-resources (heart.org in Bing)

2. Prevention & Treatment of High Cholesterol

Lifestyle guidance, risk reduction, and treatment explanations in simple language. https://www.heart.org/en/health-topics/cholesterol/prevention-and-treatment-of-high-cholesterol

3. Cholesterol – AHA Main Education Hub

Explains LDL, HDL, triglycerides, testing, prevention, and medication options. https://www.heart.org/en/health-topics/cholesterol

AHA Professional & Guideline Resources (Clinician‑Facing)

4. 2026 Guideline on the Management of Dyslipidemia (Professional Heart Daily)

Official AHA summary of the 2026 guideline, including PREVENT‑ASCVD, LDL goals, ApoB, Lp(a), and CAC updates. https://professional.heart.org/en/science-news/2026-guideline-on-the-management-of-dyslipidemia 

5. AHA Cholesterol Resources for Providers

Includes PREVENT‑ASCVD calculator, clinician pocket guides, algorithms, and patient‑shareable materials. https://www.heart.org/en/professional/quality-improvement/cholesterol-resources 

References:

Primary Guideline (Peer‑Reviewed, JACC)

1. Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of dyslipidemia. J Am Coll Cardiol. 2026;doi:10.1016/j.jacc.2025.11.016

Companion Publication (Circulation – AHA Journal)

2. Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/Multisociety guideline on the management of dyslipidemia: A report of the ACC/AHA Joint Committee on Clinical Practice Guidelines. Circulation. Published online 2026.

AHA Professional Summary

3. American Heart Association. 2026 guideline on the management of dyslipidemia. Professional Heart Daily. American Heart Association; 2026.

National Lipid Association Clinical Summary

4. National Lipid Association. 2026 ACC/AHA/Multisociety dyslipidemia guideline released. National Lipid Association Online. 2026.

Expert Commentary (Journal of Clinical Lipidology)

5. Saseen JJ, Soffer DE. The 2026 ACC/AHA/Multisociety guideline on the management of dyslipidemia: Evidence and practice alignment. J Clin Lipidol. 2026.